Put Options

31 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$27.7 - $31.39 $19.9 Million - $22.6 Million
719,400 Added 60.44%
1,909,713 $55.3 Million
Q2 2024

Aug 13, 2024

BUY
$25.26 - $29.6 $4.23 Million - $4.96 Million
167,513 Added 16.38%
1,190,313 $33.3 Million
Q1 2024

May 13, 2024

SELL
$25.89 - $29.73 $50.8 Million - $58.4 Million
-1,963,223 Reduced 65.75%
1,022,800 $28.4 Million
Q4 2023

Feb 09, 2024

BUY
$26.13 - $33.94 $43.9 Million - $57.1 Million
1,680,923 Added 128.8%
2,986,023 $86 Million
Q3 2023

Nov 09, 2023

SELL
$32.09 - $37.51 $4.04 Million - $4.73 Million
-126,000 Reduced 8.8%
1,305,100 $43.3 Million
Q2 2023

Aug 11, 2023

BUY
$36.12 - $41.79 $15 Million - $17.3 Million
414,400 Added 40.76%
1,431,100 $52.5 Million
Q1 2023

May 12, 2023

SELL
$39.39 - $51.28 $28.6 Million - $37.2 Million
-724,900 Reduced 41.62%
1,016,700 $41.5 Million
Q4 2022

Feb 08, 2023

BUY
$41.75 - $54.5 $15.8 Million - $20.6 Million
378,100 Added 27.73%
1,741,600 $89.3 Million
Q3 2022

Nov 10, 2022

SELL
$43.76 - $53.42 $29.3 Million - $35.8 Million
-670,000 Reduced 32.95%
1,363,500 $59.7 Million
Q2 2022

Aug 10, 2022

SELL
$46.53 - $55.17 $7.67 Million - $9.09 Million
-164,800 Reduced 7.5%
2,033,500 $107 Million
Q1 2022

May 16, 2022

SELL
$45.75 - $56.69 $163 Million - $202 Million
-3,558,334 Reduced 61.81%
2,198,300 $114 Million
Q4 2021

Feb 14, 2022

BUY
$41.32 - $61.25 $117 Million - $174 Million
2,841,355 Added 97.46%
5,756,634 $340 Million
Q3 2021

Nov 15, 2021

SELL
$39.25 - $50.42 $23 Million - $29.6 Million
-586,709 Reduced 16.75%
2,915,279 $125 Million
Q2 2021

Aug 13, 2021

BUY
$35.91 - $40.68 $729,978 - $826,943
20,328 Added 0.58%
3,501,988 $137 Million
Q1 2021

May 12, 2021

BUY
$33.49 - $37.77 $96.9 Million - $109 Million
2,892,407 Added 490.86%
3,481,660 $126 Million
Q4 2020

Feb 11, 2021

SELL
$33.47 - $42.56 $34.2 Million - $43.5 Million
-1,021,247 Reduced 63.41%
589,253 $21.7 Million
Q3 2020

Nov 12, 2020

SELL
$31.75 - $37.25 $631,825 - $741,275
-19,900 Reduced 1.22%
1,610,500 $59.1 Million
Q2 2020

Jul 31, 2020

SELL
$30.12 - $36.54 $8.97 Million - $10.9 Million
-297,700 Reduced 15.44%
1,630,400 $53.3 Million
Q1 2020

May 01, 2020

BUY
$27.03 - $38.62 $25.5 Million - $36.5 Million
943,900 Added 95.91%
1,928,100 $62.9 Million
Q4 2019

Feb 14, 2020

SELL
$32.92 - $37.36 $6.47 Million - $7.34 Million
-196,500 Reduced 16.64%
984,200 $38.6 Million
Q3 2019

Nov 14, 2019

BUY
$32.49 - $42.13 $18.4 Million - $23.9 Million
567,300 Added 92.48%
1,180,700 $42.4 Million
Q2 2019

Aug 14, 2019

BUY
$36.98 - $41.52 $5.65 Million - $6.34 Million
152,700 Added 33.15%
613,400 $26.6 Million
Q1 2019

May 14, 2019

SELL
$37.5 - $41.2 $31.5 Million - $34.6 Million
-840,200 Reduced 64.59%
460,700 $19.6 Million
Q4 2018

Feb 14, 2019

BUY
$38.47 - $43.86 $16.3 Million - $18.6 Million
424,700 Added 48.47%
1,300,900 $56.8 Million
Q3 2018

Nov 14, 2018

BUY
$34.47 - $41.81 $6.14 Million - $7.45 Million
178,200 Added 25.53%
876,200 $38.6 Million
Q2 2018

Aug 14, 2018

BUY
$32.98 - $35.16 $247,349 - $263,700
7,500 Added 1.09%
698,000 $25.3 Million
Q1 2018

May 15, 2018

SELL
$31.91 - $37.02 $1.37 Million - $1.59 Million
-42,900 Reduced 5.85%
690,500 $24.5 Million
Q4 2017

Feb 14, 2018

SELL
$33.26 - $35.29 $9.19 Million - $9.75 Million
-276,300 Reduced 27.36%
733,400 $26.6 Million
Q3 2017

Nov 14, 2017

BUY
$31.0 - $34.15 $19.2 Million - $21.2 Million
620,000 Added 159.1%
1,009,700 $36 Million
Q2 2017

Aug 14, 2017

SELL
N/A
-207,000 Reduced 34.69%
389,700 $13.1 Million
Q1 2017

Nov 14, 2017

BUY
N/A
596,700
596,700 $20.4 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.